SHL Medical’s COVID-19 statement
In response to the global effect of the Coronavirus (COVID-19), SHL Medical has taken proactive measures to protect the health and safety of our colleagues and ensure the continuity of business operations for our customers. As a world-leading provider of autoinjectors for major pharmaceutical companies worldwide, we are also committed to ensuring supply for the end-users of our customer’s drug delivery products.
SHL officially deployed precautionary measures in January and has since been closely monitoring the situation on a continuous basis. Our measures encompass both our business operations and employee health.
